An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of hydroxychloroquine and chloroquine therapy.


Celotto S., Veronese N., Barbagallo M., Ometto F., Smith L., Pardhan S., ...More

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, vol.103, pp.599-606, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 103
  • Publication Date: 2021
  • Doi Number: 10.1016/j.ijid.2020.12.018
  • Title of Journal : International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
  • Page Numbers: pp.599-606
  • Keywords: Hydroxychloroquine, Chloroquine, COVID-19, umbrella review

Abstract

BACKGROUND & AIMS: Hydroxychloroquine (HCQ) and chloroquine (CQ) are anti-malarial drugs frequently used in the rheumatologic field. They were recently identified as potential therapeutic options for Coronavirus Disease (COVID-19). The present study aims to map and grade the diverse health outcomes associated with HCQ/CQ using an umbrella review approach.